Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.19.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Operating activities:    
Consolidated net (loss) income $ (403.6) $ 279.6
Adjustments to reconcile consolidated net (loss) income to net cash provided by operating activities:    
Depreciation and amortization 248.8 235.3
Stock-based compensation expense 40.6 32.8
Deferred income taxes (81.7) (13.4)
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (49.9) (32.1)
Other assets, current and long-term 32.6 33.7
Current and long term liabilities, excluding debt 296.3 (28.5)
Cash provided by operating activities 83.1 507.4
Investing activities:    
Capital expenditures (305.7) (208.1)
Acquisitions, net of cash acquired (234.8) (115.8)
Cash received from sale of asset 0.0 5.6
Investment in unconsolidated affiliates, net (25.0) (6.9)
Cash used in investing activities (565.5) (325.2)
Financing activities:    
Net short-term borrowings (repayments) 367.0  
Net short-term borrowings (repayments)   (960.9)
Payments on long-term debt (50.0) (100.0)
Borrowings on long-term debt 250.0 994.5
Dividends paid to Equifax shareholders (141.4) (140.8)
Dividends paid to noncontrolling interests (4.8) (8.7)
Proceeds from exercise of stock options 15.3 11.3
Payment of taxes related to settlement of equity awards (9.7) (18.8)
Purchase of redeemable noncontrolling interests 0.0 (23.5)
Debt issuance costs 0.0 (7.6)
Payment of contingent consideration 0.0 (1.5)
Cash provided by (used in) financing activities 426.4 (256.0)
Effect of foreign currency exchange rates on cash and cash equivalents (0.1) (9.2)
Decrease in cash and cash equivalents (56.1) (83.0)
Cash and cash equivalents, beginning of period 223.6 336.4
Cash and cash equivalents, end of period $ 167.5 $ 253.4